X4 Pharmaceuticals
XFOR
XFOR
36 hedge funds and large institutions have $25.7M invested in X4 Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
10% less funds holding
Funds holding: 40 → 36 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
36
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.32M | |
| 2 | +$954K | |
| 3 | +$75.2K | |
| 4 |
BlackRock
New York
|
+$63.8K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$59K |
Top Sellers
| 1 | -$260K | |
| 2 | -$217K | |
| 3 | -$169K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$100K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$94K |